Early research (Phase 1)Looking for participantsNCT07709494
What this trial is testing
A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa
Who this might be right for
Healthy ParticipantsNon-cystic Fibrosis Bronchiectasis
Revagenix, Inc. 64